Searched for
GLAND PHARMA INSPECTION
Gland Pharma shares in focus after subsidiary Cenexi gets 11 observations from French regulatorGland Pharma shares will be in focus after its subsidiary Cenexi received 11 observations from France’s ANSM following a GMP inspection at ...
Stocks in news: Vedanta, Gland Pharma, YES Bank, Power Grid, BELMarkets experienced range-bound trading, closing slightly higher after Tuesday's dip. Vedanta Resources explores refinancing a $550 million...
USFDA issues Form 483 with 3 three observations to Gland Pharma's Visakhapatnam unitGland Pharma Ltd's facility at Visakhapatnam received three Form 483 observations from the USFDA after a recent inspection for sterile APIs...
Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cutGland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...
Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
Stocks in news: Wipro, Kotak Bank, Zomato, Motilal Oswal, Adani EnergyIT services company Wipro reported 24% growth in its consolidated net profit at Rs 3,354 crore, while revenue from operations rose by a mar...
Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata SteelThe Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25%...
Next big delta in pharma to come from biosimilars: Nithya Balasubramanian“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactica...
Stocks in news: HDFC Life, SBI, LTI Mindtree, Gland Pharma, VedantaForeign entity WWD Ruby Ltd has offloaded its entire 4.77% stake in Sapphire Foods India Ltd through the open market on Tuesday for Rs 417 ...
Gland Pharma's Hyderabad unit gets one observation from USFDA after inspection"This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA wit...
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near t...
As Covid sales spike ebbs, what lies ahead for pharma companies?Indian pharmaceutical market flattened after the pandemic led to a massive upsurge in demand for drugs. The industry saw a rise in sales du...
Sun, Cipla, Gland Pharma should do well in FY23: Nithya Balasubramanian"Sun Pharma shifted focus from generics to speciality, which seems to be doing well. Relatively they have a portfolio that is immune from p...
Stock market watch: What to expect from the week ending October 15, 2021“A convincing weekly close and bottom base moving up 17,400 to 17,630 are good signs and they hint that Nifty may go up to 18,300-400 in co...
6 pharma stocks to bet on amid Covid 2.0"The private market has opened up for vaccination and Dr Reddy’s is likely to benefit from the sale of Sputnik-V vaccine."
Pharma stocks that will ride out the Covid disruption well into next yearVaccines to combat the pandemic and a thrust on diagnostics are near-term drivers. An uptick in acute drugs and business as usual at hospit...
Why investors need to be overweight on pharmaI remain very positive on pharma. Top pick still remains Aurobindo Pharma, says Dipan Mehta.
USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
Torrent Pharma in talks to buy Glochem Industries for Rs 300 croreGlochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines.
Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...